BAYLEE KNOX: Open Payments
NPI 1245867712 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 33 payments from 17 companies in 2025. Trend: 2023 $1,558 · 2024 $1,063 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $108 |
| Ardelyx, Inc. | 4 | $99 |
| Phathom Pharmaceuticals, Inc. | 7 | $93 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| ABBVIE INC. | 2 | $35 |
| GENZYME CORPORATION | 1 | $31 |
| Astellas Pharma US Inc | 1 | $26 |
| Blueprint Medicines Corporation | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $22 |
Products named: TREMFYA, IBSRELA, VOQUEZNA, VENCLEXTA, DUPIXENT, SCEMBLIX, ENHERTU, LYNPARZA.
Industry payments across KY — which companies pay providers there.
